Treatment & Management
The research led by this Think Tank aims to optimize treatment strategies for people living and aging with HIV and STBBIs to promote long-term engagement in care, reduce comorbidities, and improve quality of life.
News
-
Unmasking the silent struggle: Living with chronic pain in the shadow of HIV
World AIDS Day December 1 is World AIDS Day, a global event that transcends borders and unites communities…
Resources
Our Resource Library is a place to share documents, videos, and training resources about HIV and STBBI research and related topics.
-
Resource CategoriesTypes
CTN+
This document updates national standards for management of adults living with both HIV and HCV in the Canadian context with evolving evidence for and accessibility of effective and tolerable DAA therapies.
Studies
The CTN+ supports clinical trials, implementation science projects, and non-interventional research of the highest scientific and ethical standards.
-
CTN 337: The FAST-TRACK Study
An open-label individual-level randomized controlled trial to compare point of care HCV RNA testing and nurse-led rapid treatment initiation to standard of care to enhance treatment uptake in persons with hepatitis C in a transient correctional setting
-
CTNPT 054: Falls in older persons with HIV
Falls in older persons with HIV: Frequency, risk factors and feasibility of a future interventional trial
-
CTNPT 052: Glycoprotein 120 as a pan-toxin
Exploring the role of the soluble glycoprotein 120 as a pan-toxin driving immune dysfunction and accelerated aging in people living with HIV
-
CTN 338: PLATINUM-CAN
Placebo-controlled randomized trial of tecovirimat in non-hospitalized patients with Mpox: Canadian Feasibility Study
-
-
CTNPT 050: Perception of menopausal hormone therapy among women living with HIV
Perception of menopausal hormone therapy amongst women living with HIV: A feasibility study for a future randomized controlled trial
Publications
Our researchers and trainees have produced hundreds of peer-reviewed publications in a wide range of HIV- and STBBI-related areas.